Presentation is loading. Please wait.

Presentation is loading. Please wait.

Economic Evaluation of the Fentanyl Transdermal System for the Treatment of Chronic Moderate to Severe Pain  Deirdre M Neighbors, BA, Timothy J Bell,

Published byDale Boone Modified over 5 years ago

Similar presentations

Presentation on theme: "Economic Evaluation of the Fentanyl Transdermal System for the Treatment of Chronic Moderate to Severe Pain  Deirdre M Neighbors, BA, Timothy J Bell,"— Presentation transcript:

1 Economic Evaluation of the Fentanyl Transdermal System for the Treatment of Chronic Moderate to Severe Pain  Deirdre M Neighbors, BA, Timothy J Bell, MHA, Jerome Wilson, PhD, Sheri L Dodd, MSc  Journal of Pain and Symptom Management  Volume 21, Issue 2, Pages (February 2001) DOI: /S (00)

2 Fig. 1 Opioid economic model
Journal of Pain and Symptom Management  , DOI: ( /S (00) )

3 Fig. 2 Titration phase (up to several days)
Journal of Pain and Symptom Management  , DOI: ( /S (00) )

4 Fig. 3 Stabilization phase (30 days)
Journal of Pain and Symptom Management  , DOI: ( /S (00) )

5 Fig. 4 Long-term use phase (through the first year)
Journal of Pain and Symptom Management  , DOI: ( /S (00) )

6 Fig. 5 Incremental cost-effectiveness of fentanyl transdermal system vs. controlled-release morphine and controlled-release oxycodone, varying utility of controlled pain with fentanyl transdermal system Journal of Pain and Symptom Management  , DOI: ( /S (00) )

Download ppt "Economic Evaluation of the Fentanyl Transdermal System for the Treatment of Chronic Moderate to Severe Pain  Deirdre M Neighbors, BA, Timothy J Bell,"

Similar presentations

Validation of the Wisconsin Brief Pain Questionnaire in a Multilingual South African Population Noko Mphahlele, MSc, Duncan Mitchell, PhD, Peter Kamerman,

Validation of the Wisconsin Brief Pain Questionnaire in a Multilingual South African Population Noko Mphahlele, MSc, Duncan Mitchell, PhD, Peter Kamerman,
Using a Morphine Equivalence Metric to Quantify Opioid Consumption: Examining the Capacity to Provide Effective Treatment of Debilitating Pain at the Global,

Using a Morphine Equivalence Metric to Quantify Opioid Consumption: Examining the Capacity to Provide Effective Treatment of Debilitating Pain at the Global,
James Womer, BA, Wenjun Zhong, PhD, F. Wickham Kraemer, MD, Lynne G

James Womer, BA, Wenjun Zhong, PhD, F. Wickham Kraemer, MD, Lynne G
Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD 

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD 
An Evaluation of the Faces Pain Scale with Young Children

An Evaluation of the Faces Pain Scale with Young Children
Transcutaneous Electrical Nerve Stimulation vs

Transcutaneous Electrical Nerve Stimulation vs
Addressing sleep problems- The role of long-acting opioids

Addressing sleep problems- The role of long-acting opioids
Neurotoxicity from Chronic Opioid Therapy After Successful Palliative Treatment for Painful Bone Metastases  Andrew Broadbent, BMedSc, MBChB, FRACP, FAChPM,

Neurotoxicity from Chronic Opioid Therapy After Successful Palliative Treatment for Painful Bone Metastases  Andrew Broadbent, BMedSc, MBChB, FRACP, FAChPM,
Clinical Trial Results with OROS® Hydromorphone

Clinical Trial Results with OROS® Hydromorphone
Winston C. -V. Parris, MD, Benjamin W. Johnson, MD, Marilyn K

Winston C. -V. Parris, MD, Benjamin W. Johnson, MD, Marilyn K
Transcutaneous Electrical Nerve Stimulation vs

Transcutaneous Electrical Nerve Stimulation vs
An Effective Treatment of Severe Complex Regional Pain Syndrome Type 1 in a Child Using High Doses of Intrathecal Ziconotide  Michael Stanton-Hicks, MD,

An Effective Treatment of Severe Complex Regional Pain Syndrome Type 1 in a Child Using High Doses of Intrathecal Ziconotide  Michael Stanton-Hicks, MD,
James Womer, BA, Wenjun Zhong, PhD, F. Wickham Kraemer, MD, Lynne G

James Womer, BA, Wenjun Zhong, PhD, F. Wickham Kraemer, MD, Lynne G
Long-Term Opioid Therapy for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety  Meredith Noble, MS, Stephen J. Tregear,

Long-Term Opioid Therapy for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety  Meredith Noble, MS, Stephen J. Tregear,
Treat the Pain Program Journal of Pain and Symptom Management

Treat the Pain Program Journal of Pain and Symptom Management
Anita L Comley, PhD, RN, AOCN, Elaine DeMeyer, RN, MSN, AOCN 

Anita L Comley, PhD, RN, AOCN, Elaine DeMeyer, RN, MSN, AOCN 
Fatigue in Gynecological Cancer Patients During and After Anticancer Treatment  Gillian Prue, PhD, James Allen, PhD, Jacqueline Gracey, PhD, Jane Rankin,

Fatigue in Gynecological Cancer Patients During and After Anticancer Treatment  Gillian Prue, PhD, James Allen, PhD, Jacqueline Gracey, PhD, Jane Rankin,
Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid- Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched,

Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid- Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched,
What Palliative Care-Related Problems Do Patients Experience at HIV Diagnosis? A Systematic Review of the Evidence  Victoria M. Simms, MSc, Irene J. Higginson,

What Palliative Care-Related Problems Do Patients Experience at HIV Diagnosis? A Systematic Review of the Evidence  Victoria M. Simms, MSc, Irene J. Higginson,
Consistency of Efficacy, Patient Acceptability, and Nasal Tolerability of Fentanyl Pectin Nasal Spray Compared with Immediate-Release Morphine Sulfate.

Consistency of Efficacy, Patient Acceptability, and Nasal Tolerability of Fentanyl Pectin Nasal Spray Compared with Immediate-Release Morphine Sulfate.

Similar presentations

Ads by Google